Outpatient coronary angioplasty, is it possible?

Original title: Assessment of Clinical Outcomes related to Early Discharge alter elective Percutaneous Coronary Intervention: COED PCI Reference: Purushothaman Muthusamy MD, et al. Catheterization and Cardiovascular Intervention 81:6-13 (2013)

The standard procedure in most institutions is that after angioplasty (PTCA) patients are discharged the next morning. There are some reports in which they were ambulatory but the safety of this has not been well established. 

The aim of this study was to analyze the results of patients who underwent PTCA and were granted discharge on the same day. We analyzed 200 consecutive patients admitted for PTCA scheduled from December 2008 to June 2011 in only one hospital. Follow-up was conducted by telephone within 24 hours and after 7 days by trained nurses.

We evaluated vascular complications, readmissions, symptoms and MACE (combination of death, myocardial infarction, urgent revascularization and pulmonary embolism). All patients received pretreatment with aspirin and clopidogrel or prasugrel. The access was femoral in 75.5% of patients with 60% utilization of a percutaneous closure device. The access was radial for the remaining 24.5%. 

Patients with femoral access stay at rest for 2-3 hours if CPB was used and 4-6 hours if it was manual compression. Ambulation time after the procedure was 4.5 ± 1.9 hours for the femoral access and 3.9 ± 1.3 hours for radial access. There was no major bleeding or MACE at 24 hours or 7 days. Minor bleeding was present in 8 patients (4%), 6 of them had femoral access. Readmission within 24 hours was 1.5%, (one patient for non-cardiac chest pain and edema in the access site). 

Within 7 days another 3 patients were readmitted (1.5%), one has pericarditis, one for non-cardiac chest pain and one having psuedoaneurisma that was resolved using a thrombin injection.

Conclusion 

Identifying angioplasty low risk patients, performing the procedure and subsequent discharge on the same day was safe with a low rate of short-term complications.

Editorial Comment:

Although this is a non-randomized study and not controlled, results are encouraging and allow lower costs and increased hospital bed availability. Hospitalization costs can be further reduced by increasing the percentage of radial access and thereby saving on percutaneous closure devices. More research is needed in this area in order to make this behavior used more often. 

Thanks to Dr Carlos Fava.
Interventional Cardiologist.
Favaloro Foundation. Argentina.

Dr. Carlos Fava para SOLACI.ORG

More articles by this author

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an emerging concern: the late loss of structural...

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as the standard treatment in patients with acute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Three-Year Outcomes of Mitral Valve-in-Valve Therapy with Balloon-Expandable Valves in the United States

Gentileza del Dr. Juan Manuel Pérez. Mitral Valve-in-Valve (MViV) implantation with balloon-expandable valves has become a solid alternative for patients with degenerated mitral bioprostheses. However,...

Edge-to-Edge Treatment in Cardiogenic Shock

Cardiogenic shock (CS) is characterized by severe ventricular dysfunction, most often of ischemic origin. It is frequently associated with severe mitral regurgitation (MR), either...